Periodontal disease as a potential risk factor for cardiovascular diseases;Choroba przyzȩbia jako potencjalny czynnik ryzyka chorób sercowo-naczyniowych

Kardiologia Polska

Volumn 66, Issue 10, 2008, Pages 1102-1106

  Zaremba, Maciej ^a   Górska, Renata ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BACTEREMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; PERIODONTAL DISEASE; REVIEW; RISK ASSESSMENT; BACTERIAL ENDOCARDITIS; BACTEROIDACEAE INFECTION; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; MICROBIOLOGY; RISK FACTOR;

BACTEROIDACEAE INFECTIONS; CARDIOVASCULAR DISEASES; ENDOCARDITIS, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; PERIODONTAL DISEASES; RISK FACTORS;

EID: 55049138005     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Opolski G (ed.) Wybrane zagadnienia z kardiologii dla studentów uczelni medycznych. Warszawa 1998; 1-124.
2. Libby P, Ridker PM, Maserati A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-43.
3. Liszewska-Pfeifer D, Koczaj M. Lipoproteina - nowy czynnik ryzyka miażdżycy? SL Zdr 1996; 17/18: 24-6.
4. Futterman LG, Lemberg L. Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors. Am J Crit Care 1998; 7: 240-4.
5. Dave S, Batista EL, Van Dyke TE. Cardiovascular disease and periodontal diseases: commonality and causation. Comp 2004; 7: 26-37.
6. Libby P, Sukhova G, Lee RT, et al. Molecular biology of atherosclerosis. Int J Cardiol 1997; 62: 23-9.
7. Nakashima Y, Raines EW, Plump AS, et al. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE- Deficient mouse. Arterioscler Thromb Vasc Biol 1998; 18: 842-51.
8. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
9. Ridker PM. Novel risk factors and markers for coronary disease. Adv Intern Med 2000; 45: 391-418.
10. Muhlestein JB. Antibiotic therapy for treatment of Chlamydia to prevent coronary heart disease events. Curr Atheroscler Rep 2000; 2: 336-41.
11. Silver JG, Martin AW, McBride BC. Experimental transient bacteriemias in human subjects with varying degrees of plaque accumulation and gingival inflammation. J Clin Periodontol 1997; 4: 92-9.
12. Daly CG, Mitchell DH, Highfield JE, et al. Bacteriemia due to periodontal probing: a clinical and microbiological investigation. J Periodontol 2000; 72: 210-4.
13. Ley BE, Linton CJ, Bennett DM, et al. Detection of bacteriemia in patients with fever and neutropenia using 16S rRNA gene amplification by PCR. Eur J Clin Microbiol Infect Dis 1998; 17: 247-53.
14. Meyer MW, Gong K, Herzberg MC. Streptoccocus sanguis-induced platelet clotting in rabbits and hemodynamic and cardiopulmonary consequences. Infect Immun 1998; 66: 5906-14.
15. Loos BG, Craandijk J, Hoeck FJ, et al. Elevation of systemic markers related to cardiovascular diseases in the peripherial blood of periodontitis patients. J Periodontol 2000; 71: 1528-34.
16. Górska R, Zaremba M, Borakowska M, et al. Wpływ flory bakteryjnej kieszonek przyzȩbnych na poziom cytokin u pacjentów z przewlekłym zapaleniem przyzȩbia. Czas Stomatol 2002; 8: 496-503.
17. Górska R, Dolegacz A, Zaremba M, et al. Wpływ flory bakteryjnej kieszonek przyzȩbnych na poziom cytokin u pacjentów z przewlekłym zapaleniem przyzȩbia i po przeszczepie nerki, leczonych immunosupresyjnie. Czas Stomatol 2002; 10: 634-40.
18. Wick G, Perschinka H, Millonig G. Atherosclerosis as an autoimmune disease: an update. Trends Immunol 2002; 22: 665-9.
19. Sims TJ, Lenmark A, Mancl LA, et al. Serum IgG to heat shock proteins and Porphyromonas gingivalis antigens in diabetic patients with periodontitis. J Clin Periodontol 2002; 29: 551-62.
20. Scannapieco FA. Role of oral bacteria in respiratory infection. J Periodontol 1999; 70: 793-802.
21. Umeda M, Kobayashi H, Takeuchi Y, et al. High prevelence of Helicobacter pylori detected by PCR in the oral cavities of periodontitis patients. J Periodontol 2003; 74: 129-34.
22. Scannapieco FA, Bush RM, Paju S. Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease and stroke: a systemic review. Ann Periodontol 2003; 8: 38-53.
23. Czerniuk MR, Górska R, Filipiak KJ, et al. Inflammatory response to acute coronary syndrome in patients with coexistent periodontal disease. J Periodontol 2004; 75: 1020-6.
24. Noack B, Genco RJ, Trevisan M, et al. Periodontal infections contribuute to elevated C-reactive protein level. J Periodontol 2001; 72: 1221-7.
25. Ishihara K, Nabuchi A, Ito R, et al. Correlation between detection rates of periodontopathic bacterial DNA in carotid coronary stenotic artery plaque and in dental plaque samples. J Clin Microbiol 2004; 3: 1313-5.
26. Zaremba M, Górska R, Suwalski P, et al. Evaluation of the incidence of periodontitis-associated bacteria in the atherosclerotic plaque of coronary blood vessels. J Preiodontol 2007; 78: 322-7.
27. Czerniuk MR, Górska R, Filipiak KJ, et al. C-reactive protein in patients with coexistent periodontal disease and acute coronary syndromes. J Clin Periodontol 2006; 33: 415-20.
28. Dorn BR, Burks JN, Seifert KN, et al. Invasion of endothelial and epithelial cells by strains of Porphyromonas gingivalis. FEMS Microbiol Lett 2000; 187: 139-44.
29. Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 1998; 66: 5337-43.
30. Kuramitsu HK, Kang IC, Qi M. Interactions of Porphyromonas gingivalis wiyh host cells: implications for cardiovascular diseases. J Periodontol 2003; 74: 85-9.
31. Qi M, Mijakawa H, Kuramitsu HK. Porphyromonas gingivalis induces murine macrophage foam cell formation. Microb Pathog 2003; 35: 259-67.
32. Mijakawa H, Honma K, Qi M, et al. Interaction of Porphyromonas gingivalis with low-density lipoproteins: implications for a role for periodontitis in atherosclerosis. J Periodontal Res 2004; 39: 1-9.
33. Li L, Messas E, Batista EL, et al. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002; 105: 861-7.
34. Lalla E, Lamster IB, Hofmann MA, et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003; 23: 1405-11.
35. Chung SW, Kang HS, Park HR. Immune responses to heat shock protein in Porphyromonas gingivalis-infected periodontitis and atherosclerosis patients. J Periodontal Res 2003; 38: 388-93.
36. Sharma A, Novak EK, Sojar HT, et al. Porphyromonas gingivalis platelet aggregation activity: outer membrane vesicles are potent activators of murine platelets. Oral Microbiol Immunol 2000; 15: 393-6.
37. Scannapieco FA. Role of oral bacteria in respiratory infection. J Periodontol 1999; 70: 793-802.
38. Hayes C, Sparrow D, Cohen M, et al. The association between alvaolar bone loss and pulmonary function: the VA Dental Longitudinal Study. Ann Periodontol 1998; 3: 257-61.
39. Scannapieco FA, Ho AW. Potential association between chronic respiratory disease and periodontal disease: analysis of National Healty and Nutrition Examination Survery III. J Periodontol 2001; 72: 50-6.
40. Scannapieco FA, Bush RM, Paju S. Periodontal disease as a risk factor for adverse pregnancy outcomes: a systemic review. Ann Periodontol 2003; 8: 70-8.
41. Han YW, Redline RW, Li M, et al. Fusobacterium nucleatum induces premature and term stillbirth in pregnant mice: implication of oral bacteria in preterm birth. Infect Immun 2004; 72: 2272-9.